Sanofi: Crohn Disease trials
The registry lists 14 Crohn Disease studies with Sanofi as lead sponsor. 4 are open to participants now and 0 have results posted.
Phase 1 2Phase 2 8Phase 3 5(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- An Open-label, DDI Study to Investigate the Effects of Duvakitug on the PK of Selected Cytochrome P450 SubstratesNot yet recruitingNCT07923383Phase 1
- A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's DiseaseRecruitingNCT07184944Phase 3
- An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's DiseaseRecruitingNCT07184931Phase 3
- A Study to Investigate Efficacy and Safety of Brivekimig in Participants With Crohn's DiseaseRecruitingNCT06958536Phase 2
- A Study to Investigate the Long-term Safety, Tolerability and Efficacy of Balinatunfib in Participants With Crohn's Disease or Ulcerative Colitis (SPECIFI-IBD-LTS)TerminatedNCT07222189Phase 2
- A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Crohn's Disease.TerminatedNCT06637631Phase 2
- Phase 2a Study of PRV-6527 in Subjects With Moderately to Severely Active Crohn's DiseaseCompletedNCT03854305Phase 2
- Study of Sargramostim in Moderately to Severely Active Crohn's DiseaseTerminatedNCT00329537Phase 2
- Efficacy (Induction of Response/Remission) and Safety Study in Patients With Moderate to Severe Crohn's DiseaseTerminatedNCT00295165Phase 3
- Efficacy Study of Sargramostim in the Retreatment of Patients Who Have Crohn's Disease Who Have Previously Responded to Treatment With SargramostimTerminatedNCT00206713Phase 3
- Open-label Trial of Leukine in Active Crohn's DiseaseTerminatedNCT00206700Phase 2
- Efficacy (Induction of Response/Remission) and Safety Study in Patients With Moderate to Severe Crohn's DiseaseCompletedNCT00206674Phase 3
- Safety and Efficacy Study in the Treatment of Pediatric Crohn's DiseaseTerminatedNCT00206661Phase 1/2
- Study in Patients With Crohn's Disease Who Are Steroid Dependent, Despite Previous Unsuccessful Attempts to Reduce Steroids Due to Worsening of Crohn's DiseaseCompletedNCT00206596Phase 2